关键信息
-
基因名
XRCC6
- 应用
-
别名
XRCC6；G22P1；X-ray repair cross-complementing Protein 6
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P12956
-
表达区间
1-609aa
-
氨基酸序列
MSGWESYYKTEGDEEAEEEQEENLEASGDYKYSGRDSLIFLVDASKAMFE SQSEDELTPFDMSIQCIQSVYISKIISSDRDLLAVVFYGTEKDKNSVNFK NIYVLQELDNPGAKRILELDQFKGQQGQKRFQDMMGHGSDYSLSEVLWVC ANLFSDVQFKMSHKRIMLFTNEDNPHGNDSAKASRARTKAGDLRDTGIFL DLMHLKKPGGFDISLFYRDIISIAEDEDLRVHFEESSKLEDLLRKVRAKE TRKRALSRLKLKLNKDIVISVGIYNLVQKALKPPPIKLYRETNEPVKTKT RTFNTSTGGLLLPSDTKRSQIYGSRQIILEKEETEELKRFDDPGLMLMGF KPLVLLKKHHYLRPSLFVYPEESLVIGSSTLFSALLIKCLEKEVAALCRY TPRRNIPPYFVALVPQEEELDDQKIQVTPPGFQLVFLPFADDKRKMPFTE KIMATPEQVGKMKAIVEKLRFTYRSDSFENPVLQQHFRNLEALALDLMEP EQAVDLTLPKVEAMNKRLGSLVDEFKELVYPPDYNPEGKVTKRKHDNEGS GSKRPKVEYSEEELKTHISKGTLGKFTVPMLKEACRAYGLKSGLKKQELL EALTKHFQD
-
分子量
93 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
XRCC6, also known as Ku70, is a critical protein involved in the repair of DNA double-strand breaks through the non-homologous end joining (NHEJ) pathway, which is essential for maintaining genomic stability. Research into XRCC6 and its recombinant protein is of significant interest due to its role in cellular response to DNA damage, implications in cancer biology, and potential as a therapeutic target. Understanding the structure and function of XRCC6 can illuminate its interactions with other repair proteins, elucidate the mechanisms of NHEJ, and reveal how its dysregulation contributes to tumorigenesis. Additionally, recombinant XRCC6 protein serves as a valuable tool in biochemical assays and structural studies, providing insights into the protein's molecular interactions and facilitating the development of novel cancer therapies. Given the increasing prevalence of DNA damage response inhibitors in cancer treatment, XRCC6's role is pivotal in both understanding treatment resistance and identifying new therapeutic strategies. As such, XRCC6 recombinant protein research continues to be an important area of focus for molecular biology and cancer research, with the potential to lead to advancements in precision medicine and targeted therapies.
